Vitromics, a Dutch biotech spin-off of Organon Technika, is developing test chips based on microarray technology, which is one of the most important analysis technologies in molecular biology research. The PamChip has a much faster analysis time than the better known DNA chips: a few minutes rather than hours. As well as DNA analysis, Vitromics is also using the same technology to examine how cells react to the administration of certain medicines. This would enable medicines with fewer side effects to be brought onto the market more efficiently. Japanese company Olympus and Belgian company Innogenetics have licensed in PamGene’s platform technology for diagnostic applications.